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A chimeric antibody-binding green fluorescent protein (ZZGFPuv) was successfully 
constructed and applied as a powerful tool for immunological diagnosis. A gene encoding 
two repetitive sequences of Z-domain, derivative of IgG-binding B domain of staphylococcal 
protein A, was fused in-frame to the N-terminus of gfpuv gene. The chimeric gene was 
subsequently transformed and expressed in various strains of E. coli. Expression of chimeric 
protein in E. coli strain HB101 resulted in a protein translocation from cytoplasm to 
periplasmic space and cultivation medium. The chimeric ZZGFPuv could be purified using 
either IgG Sepharose column or immobilized metal (Cu2+) affinity chromatography. The 
purified protein migrated in non-denaturing SDS-PAGE as two major bands. A fluorescent 
band was located at 36 kDa while another band at 48 kDa exhibited non-fluorescence. The 
fluorescent band was isolated and assessed for IgG-binding via fluorescent emission. The 
lowest amount of IgG that could be detected by dot immunobinding assay was approximately 
630 ng. Indirect immunofluorescent assay for a serological detection of leptospirosis was 
performed by using the chimeric ZZGFPuv as IgG detector.  A strong fluorescent intensity as 
comparable to that of the fluorescein isothiocyanate (FITC) conjugated system was 
significantly detected. All these findings support a high feasibility to apply the chimeric Ab-
binding GFP for clinical applications in the future. 
 




In a variety of immunoassays, secondary 
antibody is considerably accounted for the 
sensitivity of the testing system. It can 
provide a high specific binding and a 
magnification of detection signal. Tracing of 
signal can be done by chemical labeling of a 
secondary antibody with reporter molecules 
such as radioisotope, enzyme, fluorescein 
and chemiluminescent compounds (Russell 
et al., 2004). In such cases, enzyme is the 
most frequently used due to its stability and 
ease to handle. However, in many 
circumstances disadvantages arise by the 
multiple assay steps, the use of carcinogenic 
or toxic substrates and the interference of 
endogenous enzymes and substrate of the 
system. Alternatively, antibody can be 
labeled with the fluorescent compounds and 
extensively be applied in the 
immunofluorescent assay. Tagging of 
fluorescence may simply be performed by 
chemical conjugation with fluorescent 
compounds while intensity variation between 
batches is generally occurred. 
Photobleaching during assay observation is 
also another problematic factor. Therefore, 
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development of a versatile stable reagent that 
can be utilized as universal secondary 
antibodies is utmost necessary to maximize 
the immunoassay testing. Construction of a 
chimeric protein providing a stable 
fluorescence emission activity along with a 
specific binding to immunoglobulin becomes 
a particular aim of our study. 
Green fluorescent protein (GFP) is an 
autofluorescent protein isolated from the 
Pacific Northwest jellyfish, Aequorea 
victoria (Shimomura et al., 1962). It is a 
monomeric protein composed of 238 amino 
acids with molecular mass of 29 kDa. It can 
generate a green light emission (λmax = 509 
nm) upon illumination with long-wave UV 
light source (Morise et al., 1974).  Neither 
additional substrates nor cofactors except 
molecular oxygen is required (Heim et al., 
1994). GFP is a very stable molecule in 
which the fluorescence remains at high 
temperature (Tm at 78C), extreme pH (2-11), 
high molar denaturant (6 M guanidinium 
hydrochloride; GdnHCl), and prolonged 
incubation with many kinds of protease 
(Ward et al., 1982). The fluorescence is 
formed by autocatalytic cyclization of 
hexapeptide (residues 64-69) within the 
chromophore. This fluorescence can readily 
be measured using common modes of 
detection. Therefore, the GFP is widely used 
as a reporter molecule for gene expression 
(Chalfie et al., 1994), protein localization 
(Feilmeier et al., 2000; Phillips 2001), 
protein transportation (Kaether et al., 1995), 
protein binding events (Hernandez et al., 
1998), and protein fusions (Strathdee et al., 
2000). In this study, GFPuv is aimed to use 
as a reporter molecule owing to the special 
characteristics as follows: i) high efficiency 
of protein folding at 37C; ii) high solubility; 
iii) high intracellular protein diffusibility; iv) 
strong fluorescent intensity (18 times 
brighter than wild type GFP) (Crameri et al., 
1996). 
For the antibody-binding motif, much 
attention has been focused on the 
staphylococcal protein A (SpA) (Nilsson et 
al., 1987). It consists of five highly 
homologous immunoglobulin (Ig) binding 
domains in tandem (designated as domain E, 
D, A, B and C) proceeding from N to C 
termini. Each domain rearranges as a three-
helix bundle consisting of 57-60 residues 
that can independently bind Fc portion of Ig. 
It has been well established that the SpA is 
relatively stable. It is partially but reversibly 
denatured upon exposure to 6M GdnHCl.  
Furthermore, it is partly intact even after 
heating at 80C. Supportive evidence from the 
circular dichroism (CD) shows that the 
secondary structure conformation remains 
intact over a pH range of 0.99-11.8 (Sjoholm 
1975). Coupling of the SpA to certain 
enzyme has been applied as an enzyme-
conjugated secondary antibody (Falini et al., 
1980; Tuan et al., 1986). Conjugation of the 
SpA with other fluorescent and 
bioluminescent proteins at the genetic level 
further expands its application in 
immunoassay and immunological diagnosis 
(Aoki et al., 1996; Aoki et al., 2000; 
Kobatake et al, 1993). Furthermore, it has 
also been reported that secretion of protein A 
throughout the cell membrane effectively 
occurs due to the presence of SpA signal 
sequence. This opens up a feasibility to use 
such a vector containing the SpA signal 
sequence as a tool for secretion of target 
protein. 
To miniaturize the antibody-binding motif, a 
Fc-specific binding motif derived from the 
SpA B-domain (Z-domain) has been created 
and applied for protein conjugation (Nilsson 
et al., 1987). It has been stated that the Z 
domain shows a number of binding sites on 
IgG similar to SpA while providing 
significantly fewer sites on IgA, IgM and 
Fab (Ljungberg et al., 1993). This indicates a 
high specificity of the Z-domain to Fc 
portion of IgG. Owing to the small size and 
high stability, the Z-domain has successfully 
been fused to the proinsulin and insulin-like 
growth factor to facilitate protein 
purification (Nilsson et al., 1991; Kang et al., 
1994). Therefore, this study has conducted to 
engineer a chimeric gene encoding chimeric 
GFPuv carrying two repetitive sequences of 
Z-domain. Expression, purification and 
characterization of the fusion protein have 
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been performed. Feasibility of applying the 
chimeric antibody-binding GFP as a 
powerful tool for clinical application is as 
well evaluated. 
 
MATERIALS AND METHODS 
 
Plasmids and bacterial strains  
Plasmid pEZZ18 (Amersham Biosciences, 
Stockholm, Sweden) harbouring gene coded 
for double motifs of Z-domain (Nilsson et 
al., 1987) and plasmid pHis6-GFPuv 
(Prachayasittikul et al., 2000) were used for 
chimeric gene construction. E. coli strain 
HB101 (F-, thi-1, hsdS20(rB-, mB-), supE44, 
recA13, ara-14, leuB6, proA2, lacY1, 
galK2, rpsL20(strr), syl-5, mtl-1), strain 
BL21(DE3) F–, ompT, hsdSB (rB–, mB–), 
dcm, gal, λ(DE3), pLysS, Cmr, and strain 
TG1 (supE, hsdΔ5, thiΔ(lac-proAB), 
F’[traD36 proAB+ lacIq lacZΔM15] were 
used as hosts for transformation and gene 
expression. 
 
Enzymes and chemicals  
Restriction endonucleases and calf intestinal 
alkaline phosphatase were purchased from 
New England Biolabs (USA). T4 DNA 
ligase was obtained from Sibenzyme 




To construct a chimeric gene encoding two 
consecutive Fc-binding domains and GFP, a 
fragment of GFP encoding gene was cleaved 
out from the pHis6-GFPuv using SacI and 
subsequently inserted into the SacI site of 
pEZZ18, yielding a plasmid of pSZZGFP. 
The standard protocols for ligation and 
CaCl2 transformation (Sambrook et al., 
2001) were used. The in-frame fusing of 
chimeric gene was verified by restriction 
endonuclease analysis. 
 
Protein expression and purification 
Crude extract preparation 
E. coli carrying plasmid pSZZGFP were 
grown in LB medium (Tryptone 10 g/L, 
yeast extract 5 g/L and NaCl 5 g/L) 
supplemented with ampicillin 100 mg/L. The 
culture was incubated at 30C with shaking 
(150 rpm) for 24 hrs. Cells were harvested 
by spinning at 6,000 rpm for 5 min. Cells 
were resuspended in working buffer (TST 
buffer for IgG sepharose purification or 
phosphate buffer for IMAC purification, 
ingredients below) and further disrupted by 
sonic disintegration at output 5 for 10 cycles 
of 60 sec pulse-on and pulse-off. Cell debris 
was removed by centrifugation at 10,000 
rpm for 15 min. 
 
Protein purification via IgG-sepharose 
The crude extract was applied directly to an 
equilibrated IgG-sepharose column 
(Amersham Biosciences, Stockholm, 
Sweden). Unbound protein was washed out 
with 10 column volumes of TST buffer (50 
mM Tris, 150 mM NaCl, 0.05% Tween 20, 
pH 7.6) followed by 2 column volumes of 5 
mM ammonium acetate, pH 5.0. Bound 
protein was then eluted with 0.5 M acetic 
acid, pH 3.4. Fractions were immediately 
neutralized by addition of 0.5 M Tris, pH 
10.0. 
 
Protein purification via Immobilized Metal 
Affinity Chromatography (IMAC) 
Bulk protein was partially eliminated by 
heating of crude extract at 65C for 5 min. 
The denatured proteins were then 
precipitated by centrifugation at 10,000 rpm 
for 20 min. The clear supernatant was loaded 
onto the Metal Chelating Sepharose 6B 
column charged with CuSO4. After washing 
with phosphate buffer (50 mM Na HPO2 4, 0.3 
M NaCl, pH 7.4), bound protein was eluted 
upon addition of elution buffer (50 mM 
Na HPO2 4, 0.3 M NaCl, 20 mM EDTA, pH 
7.0). Green fluorescent fractions were then 
collected for further analysis. 
 
Cell fractionation 
After separating cells from extracellular 
medium, the osmotic shock was performed 
according to Brewer and Sassenfeld (Brewer 
et al., 1990) to release periplasmic protein. 
One milliliter of packed cells was 
resuspended in 8.0 mL periplasting buffer 
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(20% w/v sucrose, 30 mM Tris-HCl pH 8.0, 
1 mM EDTA, 0.15% Triton X-100). After 
leaving at room temperature for 5 min, cells 
were collected by spinning at 10,000 rpm. 
Pellet was resuspended in 4.0 mL cold water 
and swirled gently in ice bath for 10 min. 
Supernatant containing solubilized protein 
was collected by centrifugation at 6,000 rpm 
for 3 min at 4C. The spheroplasts were 
further sonicated and centrifuged at 10,000 
rpm for 10 min at 4C to separate the 
cytoplasmic and debris fraction. 
Glass slides coated with 0.5 McFarland cell 
suspension of Leptospira enterogans were 
probed with 1:10 serum from leptospirosis 
patient. Two times washing with PBS were 
done and the slides were incubated with 
various amounts of ZZGFPuv or FITC-
conjugated rabbit anti-human 
immunoglobulin (DakoCytomation, 
Glostrup, Denmark). After wash off excess 
protein or antibodies, fluorescent signal was 
detected under fluorescent microscope using 
FITC filter. 
  
Protein characterization RESULTS SDS-PAGE and immunoblotting  Proteins separation was performed on 0.1% 
SDS-12% polyacrylamide gel without heat 
denaturation. Discontinuous buffer system 
was used as described (Laemmli, 1970). For 
immunoblotting, separated proteins were 
electrotransferred to nitrocellulose 
membrane using Mini Trans-Blot 
Electrophoretic Transfer Cell (Bio-Rad 
Laboratories, USA). The membrane was 
subsequently blocked with 3% BSA and then 
probed with human immunoglobulin (50 
μg/mL). TBS (50 mM Tris, 200 mM NaCl, 
pH 7.2) was used as washing and diluting 
solution. After 3 times wash, the membrane 
was incubated with 1:2000 HRP-rabbit anti-
human immunoglobulin (DakoCytomation, 
Glostrup, Denmark). Specific bound 
antibody was then visualized by incubating 
with 0.05% 3, 3’-diaminobenzidine 
tetrahydrochloride or DAB (Zymed, USA) 
and 0.01% hydrogen peroxide in TBS. 
Construction of chimeric ZZGFPuv gene 
A plasmid pSZZGFP encoding a chimeric 
GFP carrying IgG-binding domain (Z-
domain) was successfully constructed. 
Verification of the in-frame fusing was 
performed by restriction endonuclease 
analysis. An increase in size of the 
pSZZGFP up to 5.3 kb was observed upon 
digestion with EcoRI. Addition of SacI 
resulted in the presence of two 
corresponding bands of 4.6 and 0.7 kb for 
the pEZZ18 and gfp gene, respectively (data 
not shown). A plausible conformation of the 
chimeric ZZGFPuv was illustrated in Fig. 1. 
 
Protein purification and characterization 
E. coli strain HB101 was selected as a host 
of choice for chimeric protein purification.  
Since the chimeric protein carried the Fc-
binding domain, therefore, it could easily be 
purified using IgG immobilized affinity 
chromatography. However, it is worth to 
note that the protein migrated as 2 major 
bands at approximately 48 and 36 kDa on the 
non-denaturating SDS-PAGE. These two 
bands possessed IgG binding capability 
determined by immunoblotting. The upper 
band was supposed to be the unfolding state 
of complete fusion protein with the 
calculated size of 48 kDa.  While the lower 
band rearranged as the compact form in 
which a strong fluorescent emission could be 
detected (Fig. 2). 
 
Dot-immunobinding assay  
Proteins were spotted onto nitrocellulose 
membrane and dried at room temperature. 
The immunodetection was performed as 
described earlier. 
 
Fluorescence measurement  
Fluorescence was assayed by using FLx 800 
microplate fluorescence reader (BIO-TEK, 
USA). Fluorescent emission of GFPuv at 508 
nm was measured upon excitation at 395 nm. 







Figure 1: Schematic representation of the chimeric green fluorescent protein 
carrying two consecutive regions of Fc-binding domain (ZZGFPuv). 
 
M       1         2       1        2 




Figure 2: SDS-PAGE analysis of purified ZZGFPuv. Two identical gels were 
demonstrated. Gel on the left side was Coomassie brilliant blue stained and on the 
right side was observed under UV illumination. Lane 1 represents purified protein 
isolated from SDS-PAGE gel, lane 2 represents purified protein obtained from IMAC-
Cu(II) and M indicates molecular weight marker. 
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In an attempt to isolate the fluorescent-active form, the chimeric protein was further purified 
by means of immobilized metal ion affinity chromatography charged with copper ions. 
However, the result remained the same as obtained from IgG sepharose column (Fig. 2; lane 
2). Finally, separation of the active form was carried out by cutting of the fluorescent band 
from the polyacrylamide gel. The gel fragment was then placed in a dialysis bag filled with 
Tris-HCl, pH 8.0 and the electrical current was applied to elute protein out of the gel. The 
result of the purification of ZZGFPuv was summarized in Table 1. The purified protein 
showed a great purity (Fig. 2; lane 1) with the purification fold of approximately 20 times. 
The purified ZZGFPuv possessed a specific fluorescent intensity of 4.8 x 105 RFU/mg. This 
fluorescence was approximately 2 times less than the native GFPuv. 
 















5 5) (RFU x 10 /mg)(RFU x 10
Crude 
extract 200 1240 6.2 291.0 0.2 1.0 100 
Heating at 
65C 180 378 2.1 180.8 0.5 2.5 62.1 
IMAC-Cu 70 147 2.1 149.1 1.0 5.0 51.2 
SDS-PAGE 25 10.5 0.42 50.5 4.8 24.0 17.3 
 
IgG-binding activity of the chimeric protein  
To evaluate the IgG-binding activity, the ZZGFPuv was applied as a fluorescent-labeled 
antibodies-specific ligand for fluoroimmunoassay. The detection limit of fluorescent signal 
on nitrocellulose membrane was approximately 250 ng protein/spot (Fig. 3A). The sensitivity 
of immunoglobulin-binding assay was at 630 ng Ig/spot observed under UV transilluminator 
(Fig. 3B). 
 
2.0    1.0           0.5 0.25  μg ZZGFPuv





Figure 3: (A) Various amounts of ZZGFPuv (0.25-2.0 μg) were spotted on 
nitrocellulose membrane and (B) a series of human IgG (0.63-10 μg) spotted on 
nitrocellulose membrane were probed with ZZGFPuv. The fluorescent signals 
excited by UV light were observed and captured (BIO-RAD Digi Doc). 
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Detection of Leptospira antibodies 
A feasibility of using the chimeric ZZGFPuv as a secondary labeling antibody was evaluated. 
Detection of Ab against Leptospira in patient serum was performed. The slides coated with L. 
enterogans were incubated with 3 different concentrations of ZZGFPuv (Figs. 4A-C). The 
fluorescent signal of the chimeric GFP was observed under fluorescent microscope as 
compared to the FITC-system. Non-specific binding was applied as a control by incubating 
the slides with normal serum. Our findings indicated that increasing of fluorescent intensity 
corresponded to the protein concentration. From this experiment, the minimum amount of 
300 ng of the ZZGFPuv provided a great discrimination over the background interference for 







Figure 4: Detection of antibodies against leptospira in patient serum by IFA using 
ZZGFPuv as a detection probe. Various amounts of ZZGFPuv were used; (A) 1200 
ng, (B) 300 ng and (C) 75 ng. FITC system was also used for comparison (D). Non-
specific binding was monitored by incubating leptospira-coated slide with normal 
serum before probing with chimeric protein (E) 
 
Strain-specific for chimeric protein expression 
To further investigate whether expression of the chimeric ZZGFPuv relied on specific host, 
two more strains of E. coli including TG1 and BL21 were selected for comparison. 
Expression of the chimeric protein in different hosts was monitored by measuring the 
fluorescent intensity of engineered cells. As shown in Fig. 5, the fluorescent emission was in 
the order of HB101>TG1>BL21. This indicated that expression of the chimeric ZZGFPuv 
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Figure 5: (A) Suspension of cells expressing ZZGFPuv was observed under UV 
irradiation. Fluorescent emissions of chimeric ZZGFPuv expressed in 3 strains of E. 
coli (TG1, BL21, and HB101) were compared.  (B) The fluorescent intensities of cells 
expressing ZZGFPuv were quantified by measuring fluorescent emission light (508 
nm) upon excitation with UV light (395 nm) using microplate fluorescence reader. 




Translocation of chimeric ZZGFPuv in E. coli 
Further question arose whether the presence of SpA signal sequence facilitated protein 
transportation across the bacterial membrane. A chimeric ZZGFPuv was expressed and 
secretion of the protein to the medium was investigated. Each of culture medium and crude 
extract was individually loaded onto the IgG Sepharose column. Eluate fractions were 
collected and subjected to dot-immunobinding assay. As represented in Fig. 6, the majority of 
chimeric protein was found in the crude extract. This indicated the ineffectiveness of protein 
transportation to the medium. 
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Figure 6: Dot-immunobinding assay of cultured medium (lane 1), eluate fraction 
from IgG-sepharose column of culture medium (lane 2), crude extract (lane 3), and 
eluate fraction from IgG-sepharose column of crude extract (lane 4). Panel A 
represents fractions from cell not expressing ZZGFPuv whereas panel B represents 
fraction from ZZGFPuv expressing cells. SpA 100 ng was blotted as a control (5A). 
 
To enhance the efficiency of transportation, cultivation of the engineered cells was controlled 
by the heat induction process. E. coli HB101 carrying pSZZGFP was grown in the medium at 
30C for 24 hrs. After that, one portion was kept constant at 30C while the temperature of 
another portion was raised up to 42C to induce protein secretion and continued incubating for 
3 hrs (Abrahmsen et al., 1986; Moks et al., 1987). Protein obtained from each compartment 
(extracellular, periplasm, cytoplasm and cell debris) was analyzed by both of SDS-PAGE and 
immunoblotting. As shown in Fig. 7 and Table 2, approximately 60 % of ZZGFPuv was 
secreted into the medium upon induction with the temperature shift while less than 10% was 




Figure 7:  Immunoblotting of proteins from each fraction of HB101/pSZZGFP. Panel 
A and B represent fractions from HB101/pSZZGFP cultured in heat-induced and 
normal condition, respectively. Lane 1 extracellular medium, lane 2 periplasm, lane 3 




Table 2 Protein and fluorescent determination of each compartment of E. coli strain 




fluorescenceVolume 5Fraction % yield(RFU x 10 /mg 
protein) 




      Heat shock culture (42C) 
Medium 4.2 14.1 3.36 3.46 0.25 59.1 
Periplasm 3.8 2.2 0.57 0.30 0.14 5.1 
Cytoplasm 8 19 2.38 0.75 0.04 12.8 
Cell debris 1 2.8 2.76 1.35 0.48 23 
      Normal culture (30C) 
Medium 4.3 4.4 1.03 1.37 0.31 9.1 
Periplasm 4.5 6.4 1.42 3.26 0.51 21.6 
Cytoplasm 11 28.5 2.59 3.71 0.13 24.5 





Feasibility of using chimeric antibody 
binding GFP for clinical application 
A potential approach of using a chimeric 
antibody-binding green fluorescent protein 
(ZZGFPuv) as a tool for immunological 
diagnosis has been explored. The Fc-binding 
portion (Z-domain) has successfully been 
fused to the N-terminus of the green 
fluorescent protein at the genetic level (Fig. 
1). The chimeric protein possessed dual 
characteristics of both antibody binding and 
autofluorescent emission has been 
effectively applied for detection of 
antibodies against Leptospira in patient 
serum. A strong fluorescent signal as 
comparable to that of the FITC system has 
been visualized under fluorescent 
microscope (Fig. 4). Advantages of using the 
same set of excitation/emission filter and the 
minimized photobleaching of the GFP 
compared to the FITC enlarge the scope of 
utilization (Griep et al., 1999). Furthermore, 
detection of fluorescence in real-time 
expands its applicability for single-step 
immunoblotting. The complete reaction can 
be finished within an hour, which is 
approximately 3 times faster than that of the 
conventional HRP/DAB detection system 
(Aoki et al., 2000). These findings open up a 
high feasibility to apply the chimeric 
antibody-binding GFP for clinical 
applications in the future. 
 
Characteristics of chimeric Ab-binding GFP 
Based on the previous studies, it is well 
established that the IgG binding capability of 
the staphylococcal protein A has not been 
changed dramatically upon fusion to the 
bioluminescent or fluorescent molecule 
(Aoki et al., 1996; Kobatake et al., 1993). 
Meanwhile, little is known on the other Ig-
binding protein derivatives. In this study, we 
report for the first time the binding affinity to 
IgG of the Fc-binding monodomain (Z-
domain) derived from the B-domain of 
staphylococcal protein A. Two consecutive 
sequences of Z-domain possess a strong 
binding interaction to immobilized IgG while 
maintaining a strong fluorescent emission 
(Fig. 3B). This high binding affinity and 
specificity to IgG as comparable to the SpA 
native domain has been reported (Jansson et 
al., 1998). However, the relative smaller size 
and high protein solubility are also being 
counted as its advantages. Furthermore, the 
stability against hydroxylamine and 
cyanogen bromide due to the substitution of 
Ala1 Æ Val and Gly29 Æ Ala makes it more 
reliable than the B-domain. 
 
The presence of active form (fluorescent 
band; migrated at 36 kDa) and inactive form 
(non-fluorescent band; migrated at 48 kDa) 
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of chimeric ZZGFPuv have been observed 
on the non-denaturation SDS-PAGE (Fig. 2). 
While, a complete denaturation upon heat 
treatment (95C, 5 min) reveals a single band 
at 48 kDa. These findings indicate that the 36 
kDa band exhibits a compact conformation 
of folded state while the 48 kDa band 
represents an unfolded state of ZZGFPuv. 
Similar evidences have also been reported 
demonstrating that some portions of chimeric 
protein A-GFP and protein G-EGFP 
expressed in E. coli remain in inactive state 
(Aoki et al., 1996; Arai et al., 1998). It is 
worth to mention that active form of 
antibody-binding GFPs (ZZGFPuv, protein 
A-GFP and protein G-EGFP) moves faster 
than the inactive form in non-denaturing gel. 
Contrarily, the opposite mobility pattern has 
been found in the wild-type GFP (Inouye et 
al., 1994). A plausible explanation is that 
incorporation of a certain amount of sodium 
dodecyl sulphate (SDS) to the antibody-
binding portion facilitates a larger extent on 
protein mobility than the GFP molecule. 
However, effects of isoelectric point and 
hydrophilicity between these two molecules 
have to be taken into consideration (Aoki et 
al., 2002; Aoki et al., 2003). 
 
Expression and localization of chimeric Ab-
binding GFP in E. coli 
Based on our findings, bacterial host strain 
as well as the presence of signal peptide is a 
major factor affecting the expression and 
localization of chimeric ZZGFPuv. E. coli 
strain HB101 has experimentally been 
proven to be a suitable host for high level 
expression and secretion of chimeric 
ZZGFPuv throughout the cellular membrane 
(Figs. 5 and 7). A gene encoding ZZGFPuv 
has been placed downstream of the SpA 
signal sequence and the gene expression has 
been regulated by the SpA promoter, in 
which the secretion of heterologous protein 
can successfully be potentiated in E. coli. 
The presence of SpA signal sequence 
facilitates protein translocation from 
cytoplasm to extracellular via the Sec 
pathway. For circumstances, the insulin-like 
growth factor I (IGF-I) and proinsulin with 
complete function have successfully been 
secreted by this system (Kang et al., 1994; 
Loewenadler et al., 1987). Since the GFP has 
a unique structure and relatively larger than 
the IGF-I and proinsulin, we doubt whether a 
mature GFP can be secreted throughout the 
cell membrane by the same system. From our 
findings, the ZZGFPuv has successfully been 
secreted to the periplasm and the medium. 
However, notification has to be made that 
induction of temperature up to 42C in the 
cultivation process facilitates the protein 
transportation up to 60%. Supportive 
evidences on the production of protein 
content (up to 20 folds) and the enhancement 
of secreted product upon temperature shift 
after stationary phase have also been 
reported (Abrahmsen et al., 1986). Our 
studies lend support the notion that 
expression and secretion of the GFP can be 
obtained via the Sec-dependent protein 
translocation. Feilmeier et al. (2000) have 
previously demonstrated that the GFP can be 
exported to the periplasmic space by fusing 
with the maltose-binding protein carrying a 
typical Sec-dependent signal peptide. 
However, the GFP hybrid protein in 
periplasm exhibits a complete non-
fluorescent indicating the improper folding. 
In contrast, Casey et al have demonstrated 
the successfulness of periplasmic expression 
of fluorescent GFP upon fusion with the 
scFv and PelB signal sequence (Casey et al., 
2000). In our case, some portion of the 
ZZGFPuv (approximately 40%) remains 
located inside the cells (Table 2). The 
presence of protein residual in cell debris 
may be attributable to the binding interaction 
between the hydrophobic region of the signal 
sequence and lipid membrane. This 
phenomenon has been evidenced by the 
incorporation of chimeric cadmium-binding 
GFP to the inner membrane of E. coli 
(Prachayasittikul et al., 2004). 
 
Future perspectives 
Future perspectives for the development of a 
versatile reagent for clinical application are 
now taken as the ongoing research in our lab. 
For instances, genetic re-manipulations of 
the chimeric Ab-binding GFP are needed to 
be performed in order to attain a high level 
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protein expression. These include 
construction of the chimeric gene encoding 
chimeric GFP carrying the repetitive 
sequences of Z-domain on the C-terminus in 
which the high level fluorescent emission 
can be obtained. Expression of cytoplasmic 
chimeric Ab-binding GFP without the signal 
peptide is performed. Since the presence of 
signal peptide e.g. CAT and PelB has been 
reported to reduce the gene expression while 
production of the protein A and protein G 
fused to GFP intracellularly yield the protein 
content up to 30 mg/L (Griep et al., 1999; 
Arai et al., 1998; Casey et al., 2000; Fujino 
et al., 2002). 
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